UM Biointerfaces

Biointerfaces Institute - a new blueprint for interdisciplinary collaboration in the biomedical sciences at the University of Michigan

[UM Biointerfaces @UMBiointerfaces]

Welcome back! 2025 Reflections & a Bold Vision for 2026

https://t.co/iJ2IXpd9hZ

[UM Biointerfaces @UMBiointerfaces]

The December 2025 Michigan Research newsletter highlights how U-M researchers are turning bold ideas into real-world solutions featuring work by Dr. Cindy Chestek.

Read More Here:
https://t.co/7rZULI0FjT

[UM Biointerfaces @UMBiointerfaces]

Researchers have developed a blood-based test that can indicate whether brain cancer treatment is working without invasive procedures. Could adjust therapies earlier, reduce uncertainty, and move cancer care closer to truly personalized treatment.

Read:
https://t.co/5fVJqnOSPS

[UM Biointerfaces @UMBiointerfaces]

We are thrilled to announce that @NagrathSunitha has been named the Dwight F. Benton Professor of Chemical Engineering! In celebration of Dr. Nagrath’s innovative leadership in microfluidics and cancer diagnostics, congratulations!

Read More Here:
https://t.co/z18d1BMPJf

[UM Biointerfaces @UMBiointerfaces]

Congratulations to Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier on being named as apart of 2025's World's Top 2% Scientists Network!

Read More Here:
https://t.co/kAqLyBfxbA

[UM Biointerfaces @UMBiointerfaces]

Using advanced mass-spectrometry techniques, researchers uncovered significant physicochemical differences across different lots of this widely used therapeutic antibody.

Read More Here:
https://t.co/qUJPBxVfkb

[UM Biointerfaces @UMBiointerfaces]

The Biointerfaces Institute wants to remind you to be safe during this colder season! Be sure to practice safe conduct both on and off campus to avoid any injuries or accidents!

[UM Biointerfaces @UMBiointerfaces]

Deepak Nagrath's lab has a fresh look at how we study brain-cancer metabolism in real human patients, not just cell lines. The new study introduces two ML-based methods: a “digital-twin” and a “13C-scMFA” approach.

Read More Here:
https://t.co/zBSHyQhvBb

[UM Biointerfaces @UMBiointerfaces]

Under the guidance of co-inventor and VP of Technology, Dr. Joerg Lahann, GreenMark Biomedical Inc. has secured its third National Institutes of Health (NIH) SBIR grant in 2025 to advance its novel CrystLCare™ biorestorative dental strip.

Read More Here:
https://t.co/2ELwb2lH9B

[UM Biointerfaces @UMBiointerfaces]

Thrilled to see eight new Postdoctoral Commercialization Fellows selected by UM’s Innovation Partnerships.

Read Here:
https://t.co/XFAS8rIQez

[UM Biointerfaces @UMBiointerfaces]

Skeletalis has raised $8M to advance its next-generation small-molecule therapy for osteoporosis, backed by Pillar VC, KdT Ventures, age1, and Slocum Management.

Read Here:
https://t.co/ON9cmv1Kyb

[UM Biointerfaces @UMBiointerfaces]

Congratulations on the Kotov Lab for winning the Best Department Spirit Award at the ChE 5K Fun Run!

[UM Biointerfaces @UMBiointerfaces]

New study conducted by Dr. Sunitha Nagrath's lab, with the Fariba Behbod lab at the University of Kansas, shows detectable circulating tumor cells in DCIS pointing to early dissemination and new opportunities for better risk stratification.

Read Here:
https://t.co/xjrkJneE1a

[UM Biointerfaces @UMBiointerfaces]

Dr. Peter Tessier’s team is designing biologics that “hitchhike” on the brain’s natural transport pathways, enabling safer, targeted delivery of antibodies, proteins, and gene therapies.

Read More Here:
https://t.co/Rh2Yx0kafj

[UM Biointerfaces @UMBiointerfaces]

Skeletalis is now live, driven by Colin Greineder's pioneering work in bone-targeted therapeutics.

Their team is rethinking how osteoporosis drugs interact with bone, aiming for safer, more durable therapies that truly meet patient needs.

Learn more:
https://t.co/xrYF0y9l6A

[UM Biointerfaces @UMBiointerfaces]

@castro2355_mg and her team have received a 7-year, $4.5 million NIH grant to expand brain tumor research focused on IDH1-mutant gliomas, aggressive tumors, that often affect younger adults.

Read Here:
https://t.co/I8gQtlH3eG

[UM Biointerfaces @UMBiointerfaces]

Kotov Group PhD Candidate Kody Whinsant received a presentation award at the American Institute of Chemical Engineers (AlChE) Nanoscale Science and Engineering Forum (NSEF) Graduate Student Poster Competition at the 2025 AlChE Annual Meeting in Boston.

Congratulations Kody!

[UM Biointerfaces @UMBiointerfaces]

Exciting new research led by Dr. James Moon and collaborators shows how large language models can transform single-cell omics. Unlocking faster, smarter insights into how our cells behave and respond to disease.

Read More Here:
https://t.co/pVgwYYRKh8

[Aditya S. Pandey @Aditya_S_Pandey]

Congratulations to our own Dr. Maria Castro @umichneuro for being awarded the prestigious Javits Neuroscience Investigator Award for a career filled with impactful contributions to Brain Tumor Science! @UMRogelCancer @umichmedicine @UMneurosciences

[UM Biointerfaces @UMBiointerfaces]

At BI, health research is being turned inside out. Instead of starting with individual labs and hoping collaboration follows, BI begins with collaboration. Bringing together clinicians, engineers, chemists, and data scientists from the start.

Read here:
https://t.co/YnfYppHt6T